HealthKois has launched a target corpus of $ 300 million, and an additional green shoe option of $ 100 million. The fund has been established by the key leadership team behind HealthQuad—Charles Janssen, Managing Partner; Ajay Mahipal, Partner; and Dr Pinak Shrikhande, Partner. As a successor fund to HealthQuad, HealthKois aims to accelerate India’s healthcare evolution by investing in technology-enabled, scalable, and high-impact enterprises.
HealthKois aims to deliver top-tier risk-adjusted financial returns alongside measurable societal impact. Over the next four years, the firm will invest between $ 7 million to $ 25 million per company in early growth-stage businesses operating across HealthTech, Life Sciences, MedTech, Healthcare Delivery and Climate Health. The fund is focused on supporting companies that offer robust operational scalability, demonstrable clinical outcomes, and sustainable infrastructure solutions.
According to a press statement, HealthKois will back technology-led and innovative healthcare companies that address critical gaps in accessibility, affordability, and quality of care.
HealthKois builds upon the legacy of HealthQuad Funds I and II, which have successfully backed companies that have touched over 90 million lives and serve 8.2 million patients annually. HealthQuad Funds I and II will continue to operate under the existing framework.
